Ovarian Cancer Canada’s national 2026 Breakthrough Fund Competition will invest $1 million in leading-edge pragmatic clinical trials with the greatest potential to advance the early detection and precision treatment of ovarian cancer. 

 

Join Ovarian Cancer Canada Research staff for an informative webinar exploring this unique funding opportunity. The session will highlight the competition’s focus on innovative, patient-centered research that can be integrated into the existing healthcare system. 

 

Participants will also learn about key timelines and application requirements, including: 

• Meaningful engagement of patients as research partners 
• An integrated pathway to commercialization 
• Consideration of equity, diversity, and inclusion (EDI) principles in study design 

The webinar will be offered in English only. A recording will be made available to registered participants who are unable to attend the live session.